Cargando…

The prognostic significance of apoptosis-associated proteins BCL-2, BAX and BCL-X in clinical nephroblastoma

Apoptotic cell death represents an important mechanism for the precise regulation of cell numbers in normal tissues. Various apoptosis-associated regulatory proteins, such as Bcl-2, Bax and Bcl-X, may contribute to the rate of apoptosis in neoplasia. The present study was performed to evaluate the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghanem, M A, Kwast, T H Van der, Hollander, J C Den, Sudaryo, M K, Heuvel, M M Van den, Noordzij, M A, Nijman, R J M, Soliman, E H, Steenbrugge, G J van
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363928/ https://www.ncbi.nlm.nih.gov/pubmed/11720445 http://dx.doi.org/10.1054/bjoc.2001.2146

Ejemplares similares

Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2
por: Schuyer, M, et al.
Publicado: (2001)

Prostate tumours from an Asian population: examination of bax, bcl-2, p53 and ras and identification of bax as prognostic marker
por: Chia, S-J, et al.
Publicado: (2000)

Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status
por: Mirjolet, J-F, et al.
Publicado: (2000)

The Action of Bax and Bcl-2 on T Cell Selection
por: Williams, Owen, et al.
Publicado: (1998)

Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy?
por: Kulsoom, Bibi, et al.
Publicado: (2018)

Characterization and prognostic significance of mortalin, Bcl-2 and Bax in intrahepatic cholangiocarcinoma
por: Kang, Qiang, et al.
Publicado: (2018)

Mitigation of apoptosis-mediated neurotoxicity induced by silver nanoparticles via rutaceae nutraceuticals: P53 activation and Bax/Bcl-2 regulation
por: Abdel-Megeed, Rehab M., et al.
Publicado: (2022)

Lack of Bcl10 mutations in testicular germ cell tumours and derived cell lines
por: Schothorst, E M van, et al.
Publicado: (1999)

Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance.
por: Tollenaar, R. A., et al.
Publicado: (1998)

Abdominal Radiotherapy: A Major Determinant of Metabolic Syndrome in Nephroblastoma and Neuroblastoma Survivors
por: van Waas, Marjolein, et al.
Publicado: (2012)

Bcl-w expression in colorectal adenocarcinoma
por: Wilson, J W, et al.
Publicado: (2000)

Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus
por: Zhai, Y-L, et al.
Publicado: (1999)

The predictive value of immunohistochemical markers in untreated Wilms’ tumour: are they useful?
por: Ghanem, Mazen A., et al.
Publicado: (2011)

Bcl-XL Inhibits Membrane Permeabilization by Competing with Bax
por: Billen, Lieven P, et al.
Publicado: (2008)

p27 Deficiency Cooperates with Bcl-2 but Not Bax to Promote T-Cell Lymphoma
por: Cheng, Ningli, et al.
Publicado: (2008)

Mutations in Bcl10 are very rare in colorectal cancer
por: Stone, J G, et al.
Publicado: (1999)

Retinal ischemia-induced apoptosis is associated with alteration in Bax and Bcl-x(L) expression rather than modifications in Bak and Bcl-2
por: Produit-Zengaffinen, Nathalie, et al.
Publicado: (2009)

Apoptosis, cell proliferation and expression of Bcl-2 and Bax in gastric carcinomas: immunohistochemical and clinicopathological study.
por: Koshida, Y., et al.
Publicado: (1997)

Chemoprevention of intestinal tumorigenesis by nabumetone: induction of apoptosis and Bcl-2 downregulation
por: Roy, H K, et al.
Publicado: (2001)

Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviour
por: Turner, H E, et al.
Publicado: (2000)

Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues
por: Schaik, R H N van, et al.
Publicado: (2000)

Expression of Apoptotic Markers Bcl-2 and Bax in the Vascular Wall
por: Klimentova, E.A., et al.
Publicado: (2021)

Opposite role of Bax and BCL-2 in the anti-tumoral responses of the immune system
por: Bougras, Gwenola, et al.
Publicado: (2004)

Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma
por: de Jong, Yvonne, et al.
Publicado: (2018)

Human VRK2 modulates apoptosis by interaction with Bcl-xL and regulation of BAX gene expression
por: Monsalve, D M, et al.
Publicado: (2013)

Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen
por: Kupryjańczyk, J, et al.
Publicado: (2003)

Photodynamic Therapy Using a Novel Phosphorus Tetraphenylporphyrin Induces an Anticancer Effect via Bax/Bcl-xL-related Mitochondrial Apoptosis in Biliary Cancer Cells
por: Mai, Nguyen Nhat Huynh, et al.
Publicado: (2020)

Expression and Prognostic Significance of Bcl-2 and Bax in The Progression and Clinical Outcome of Transitional Bladder Cell Carcinoma
por: Golestani Eimani, Bahram, et al.
Publicado: (2014)

Bcl-2 Family Members Bcl-xL and Bax Cooperatively Contribute to Bortezomib Resistance in Mantle Cell Lymphoma
por: Luanpitpong, Sudjit, et al.
Publicado: (2022)

Bcl-2 overexpression blocks caspase activation and downstream apoptotic events instigated by photodynamic therapy
por: Granville, D J, et al.
Publicado: (1999)

Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B
por: Rooswinkel, R W, et al.
Publicado: (2012)

Apparent diffusion coefficient as it relates to histopathology findings in post-chemotherapy nephroblastoma: a feasibility study
por: Littooij, Annemieke S., et al.
Publicado: (2017)

Effect of L-carnitine on the expression of the apoptotic genes Bcl-2 and Bax
por: Vardiyan, Reyhane, et al.
Publicado: (2020)

Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer
por: Borner, M M, et al.
Publicado: (1999)

Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance.
por: Williamson, K. E., et al.
Publicado: (1998)

Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells
por: Pidgeon, G P, et al.
Publicado: (2001)

Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer
por: Lopez, Andrea, et al.
Publicado: (2022)

Aberrant immunoexpression of p53 tumour-suppressor and Bcl-2 family proteins (Bcl-2 and Bax) in ameloblastomas and odontogenic keratocysts
por: Escobar, Enrico, et al.
Publicado: (2023)

Apoptosis and the activity of ceramide, Bax and Bcl-2 in the lungs of neonatal rats exposed to limited and prolonged hyperoxia
por: Husari, Ahmad W, et al.
Publicado: (2006)

Low expression of bcl-2 in Brca1-associated breast cancers
por: Freneaux, P, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_a2vq9815eppjm3ubterork41n9